| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine (C.M.B., R.W.), Physiology (J.W.K.), and Obstetrics and Gynecology (D.H.A), National Primate Research Center (S.T.B., R.J.C., J.R.E., J.W.K., D.H.A.), and Institute on Aging (R.J.C., J.W.K., R.W.), University of Wisconsin, Madison, Wisconsin 53792; Cato Research (J.R.E.), Durham, North Carolina 27713; and Geriatric Research, Education, and Clinical Center, Veterans Administration Hospital (R.W.), Madison, Wisconsin 53705
Address all correspondence and requests for reprints to: Dr. Cristin M. Bruns, 600 Highland Avenue, H4/568 CSC (5148), Madison, Wisconsin 53792. E-mail: cb2{at}medicine.wisc.edu.
Polycystic ovary syndrome (PCOS) is a familial disease. Affected males harbor some of the metabolic deficits seen in affected females. The prenatally androgenized (PA) female rhesus monkey, an animal model for PCOS, manifests glucoregulatory and reproductive abnormalities similar to those seen in PCOS women. The purpose of this study was to determine whether exposure of fetal male rhesus monkeys to testosterone excess would induce glucoregulatory and reproductive deficits. Seven adult PA males and seven matched controls underwent somatometric measurements, sex steroid analysis, and a frequently sampled iv glucose tolerance test. Body measurements were similar in the two groups, although arm circumference was greater in control compared with PA males (P < 0.01). There were no differences in neonatal weight or serum levels of sex steroids between the two male groups. Measures of insulin sensitivity and pancreatic ß-cell compensation (disposition index) were clearly diminished in PA compared with control males [insulin sensitivity: PA, mean 0.8 (95% confidence interval, 0.11, 5.82); controls, 3.06 (1.51, 6.19) x 104/min/µU/ml; P < 0.05; disposition index: PA, 226.38 (69.54, 383.22); controls, 509.21/min (306.52, 711.89); P < 0.02]. PA males do not exhibit elevated androgens during adulthood, suggesting that insulin resistance and impaired pancreatic ß-cell function may result from fetal reprogramming of key metabolic tissues.
This article has been cited by other articles:
![]() |
S. Palomba, A. Falbo, F. Zullo, and F. Orio Jr. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocr. Rev., February 1, 2009; 30(1): 1 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Recabarren, P. P. Rojas-Garcia, M. P. Recabarren, V. H. Alfaro, R. Smith, V. Padmanabhan, and T. Sir-Petermann Prenatal Testosterone Excess Reduces Sperm Count and Motility Endocrinology, December 1, 2008; 149(12): 6444 - 6448. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, M. Acosta-Martinez, T. H. Horton, and J. E. Levine Fasting-induced suppression of LH secretion does not require activation of ATP-sensitive potassium channels Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1439 - E1446. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Demissie, M. Lazic, E. M. Foecking, F. Aird, A. Dunaif, and J. E. Levine Transient prenatal androgen exposure produces metabolic syndrome in adult female rats Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E262 - E268. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Recabarren, R. Smith, R. Rios, M. Maliqueo, B. Echiburu, E. Codner, F. Cassorla, P. Rojas, and T. Sir-Petermann Metabolic Profile in Sons of Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1820 - 1826. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.F. Escobar-Morreale, G. Villuendas, J.I. Botella-Carretero, F. Alvarez-Blasco, R. Sanchon, M. Luque-Ramirez, and J.L. San Millan Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study Hum. Reprod., September 1, 2006; 21(9): 2257 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M Carlsen, G Jacobsen, and P Romundstad Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur. J. Endocrinol., August 1, 2006; 155(2): 365 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Xita and A. Tsatsoulis Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess: Evidence from Experimental, Clinical, and Genetic Association Studies J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1660 - 1666. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |